Bamshad, M. J., Nickerson, D. A. & Chong, J. X. Mendelian gene discovery: fast and furious with no end in sight. Am. J. Hum. Genet. 105, 448–455 (2019).
Article CAS PubMed PubMed Central Google Scholar
Boycott, K. M. et al. A diagnosis for all rare genetic diseases: the horizon and the next frontiers. Cell 177, 32–37 (2019).
Article CAS PubMed Google Scholar
Boycott, K. M., Azzariti, D. R., Hamosh, A. & Rehm, H. L. Seven years since the launch of the Matchmaker Exchange: the evolution of genomic matchmaking. Hum. Mutat. 43, 659–667 (2022).
CAS PubMed PubMed Central Google Scholar
Wilczewski, C. M. et al. Genotype first: clinical genomics research through a reverse phenotyping approach. Am. J. Hum. Genet 110, 3–12 (2023).
Article CAS PubMed PubMed Central Google Scholar
Gargano, M. A. et al. The Human Phenotype Ontology in 2024: phenotypes around the world. Nucleic Acids Res. https://doi.org/10.1093/nar/gkad1005 (2023).
Carmody, L. C. et al. The Medical Action Ontology: a tool for annotating and analyzing treatments and clinical management of human disease. Med 4, 913.e3–927.e3 (2023).
Danis, D. et al. Phenopacket-tools: building and validating GA4GH Phenopackets. PLoS ONE 18, e0285433 (2023).
Article CAS PubMed PubMed Central Google Scholar
Ladewig, M. S. et al. GA4GH Phenopackets: a practical introduction. Adv. Genet. 4, 2200016 (2023).
Article CAS PubMed Google Scholar
Jacobsen, J. O. B. et al. The GA4GH Phenopacket schema defines a computable representation of clinical data. Nat. Biotechnol. 40, 817–820 (2022).
Article CAS PubMed PubMed Central Google Scholar
Bick, D., Jones, M., Taylor, S. L., Taft, R. J. & Belmont, J. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. J. Med. Genet. 56, 783–791 (2019).
Australian Genomics Health Alliance Acute Care Flagship et al. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian Public Health Care System. JAMA 323, 2503–2511 (2020).
Costain, G., Cohn, R. D., Scherer, S. W. & Marshall, C. R. Genome sequencing as a diagnostic test. CMAJ 193, E1626–E1629 (2021).
Article CAS PubMed PubMed Central Google Scholar
Costain, G. et al. Genome sequencing as a diagnostic test in children with unexplained medical complexity. JAMA Netw. Open 3, e2018109 (2020).
Article PubMed PubMed Central Google Scholar
Haque, B. et al. Contemporary aetiologies of medical complexity in children: a cohort study. Arch. Dis. Child. 108, 147–149 (2023).
Costain, G., Chow, E. W., Ray, P. N. & Bassett, A. S. Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. J. Intellect. Disabil. Res. 56, 641–651 (2012).
Article CAS PubMed Google Scholar
Pena, L. D. M. et al. Contributions from medical geneticists in clinical trials of genetic therapies: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 25, 100831 (2023).
Gleeson, J. G. et al. Personalized antisense oligonucleotides ‘for free, for life’ - the n-Lorem Foundation. Nat. Med. 29, 1302–1303 (2023).
Article CAS PubMed Google Scholar
Fanos, J. H. New “first families”: the psychosocial impact of new genetic technologies. Genet. Med. 14, 189–190 (2012).
Lee, W. et al. Genome sequencing among children with medical complexity: what constitutes value from parents’ perspective? J. Genet. Couns. 31, 523–533 (2022).
Vandeborne, L., van Overbeeke, E., Dooms, M., De Beleyr, B. & Huys, I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J. Rare Dis. 14, 99 (2019).
Article PubMed PubMed Central Google Scholar
Diskin, C. et al. Research priorities for children with neurological impairment and medical complexity in high-income countries. Dev. Med. Child Neurol. https://doi.org/10.1111/dmcn.15037 (2021).
Nelson, K. E. et al. Clinical characteristics of children with severe neurologic impairment: a scoping review. J. Hosp. Med. 18, 65–77 (2023).
Gill, P. J. et al. Patient, caregiver, and clinician participation in prioritization of research questions in pediatric hospital medicine. JAMA Netw. Open 5, e229085 (2022).
Article PubMed PubMed Central Google Scholar
Jacquemont, S. et al. Genes To Mental Health (G2MH): a framework to map the combined effects of rare and common variants on dimensions of cognition and psychopathology. Am. J. Psychiatry 179, 189–203 (2022).
Article PubMed PubMed Central Google Scholar
Commission on Novel Technologies for Neurodevelopmental Copy Number Variants. Neurodevelopmental copy-number variants: a roadmap to improving outcomes by uniting patient advocates, researchers, and clinicians for collective impact. Am. J. Hum. Genet. 109, 1353–1365 (2022).
Hanly, C., Shah, H., Au, P. Y. B. & Murias, K. Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: a scoping review. Clin. Genet. 99, 335–346 (2021).
Article CAS PubMed Google Scholar
McTague, A. et al. Defining causal variants in rare epilepsies: an essential team effort between biomedical scientists, geneticists and epileptologists. Eur. J. Med. Genet. 65, 104531 (2022).
Article CAS PubMed Google Scholar
Perlman, P. et al. Support to caregivers who have received genetic information about neurodevelopmental and psychiatric vulnerability in their young children: a narrative review. Clin. Genet. 104, 163–173 (2023).
Article CAS PubMed Google Scholar
Baribeau, D. A. et al. Developmental implications of genetic testing for physical indications. Eur. J. Hum. Genet. 30, 1297–1300 (2022).
Article PubMed PubMed Central Google Scholar
Altmuller, F. et al. Genotype and phenotype spectrum of NRAS germline variants. Eur. J. Hum. Genet. 25, 823–831 (2017).
Article PubMed PubMed Central Google Scholar
Armour, C. M. & Allanson, J. E. Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations. J. Med. Genet. 45, 249–254 (2008).
Article CAS PubMed Google Scholar
Bassett, A. S. et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am. J. Med. Genet. A 138, 307–313 (2005).
Article PubMed PubMed Central Google Scholar
Fung, W. L. et al. Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet. Med. 17, 599–609 (2015).
Article CAS PubMed PubMed Central Google Scholar
Kapadia, R. K. & Bassett, A. S. Recognizing a common genetic syndrome: 22q11.2 deletion syndrome. CMAJ 178, 391–393 (2008).
Article PubMed PubMed Central Google Scholar
Kidd, S. A. et al. Fragile X syndrome: a review of associated medical problems. Pediatrics 134, 995–1005 (2014).
Korenberg, J. R. et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl Acad. Sci. USA 91, 4997–5001 (1994).
Article CAS PubMed PubMed Central Google Scholar
Mautner, V. F. et al. Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J. Med. Genet. 47, 623–630 (2010).
Article CAS PubMed Google Scholar
Pasmant, E., Vidaud, M., Vidaud, D. & Wolkenstein, P. Neurofibromatosis type 1: from genotype to phenotype. J. Med. Genet. 49, 483–489 (2012).
Article CAS PubMed Google Scholar
Chung, W. K. et al. Genomic medicine implementation protocols in the PhenX Toolkit: tools for standardized data collection. Genet. Med. 23, 1783–1788 (2021).
Article PubMed PubMed Central Google Scholar
Tan, T. Y. et al. Bi-allelic ADARB1 variants associated with microcephaly, intellectual disability, and seizures. Am. J. Hum. Genet. 106, 467–483 (2020).
Comments (0)